Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

"Efesovir" (FS-1) for COVID-19, Phase 2

  • Read more about "Efesovir" (FS-1) for COVID-19, Phase 2

Biomarkers of LONG COVID (LONG COVID_LCM)

  • Read more about Biomarkers of LONG COVID (LONG COVID_LCM)

University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry

  • Read more about University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

  • Read more about A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

Effects of Inpatient Rehabilitation Measures in Long-COVID-19 Syndrome

  • Read more about Effects of Inpatient Rehabilitation Measures in Long-COVID-19 Syndrome

An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older

  • Read more about An Open Comparative Study of the Effectiveness and Incomparable Study of the Immunogenicity and Safety of the Vaccine (CoviVac) for Adults Aged 60 Years and Older

Characteristics of Long COVID-19 Syndrome

  • Read more about Characteristics of Long COVID-19 Syndrome

Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.

  • Read more about Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

  • Read more about Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine

  • Read more about Phase I Clinical Trial With New SARS-CoV-2 CoVacHGMix Type 5 Adenoviral Vector Vaccine

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • Current page 131
  • Page 132
  • Page 133
  • Page 134
  • Page 135
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA